0001415889-23-000289.txt : 20230104 0001415889-23-000289.hdr.sgml : 20230104 20230104161157 ACCESSION NUMBER: 0001415889-23-000289 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230101 FILED AS OF DATE: 20230104 DATE AS OF CHANGE: 20230104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Huber Martin H. Jr. CENTRAL INDEX KEY: 0001653276 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40925 FILM NUMBER: 23506470 MAIL ADDRESS: STREET 1: C/O TESARO, INC. STREET 2: 1000 WINTER STREET, SUITE 3300 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xilio Therapeutics, Inc. CENTRAL INDEX KEY: 0001840233 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851623397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-833-1027 MAIL ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-01042023_090139.xml X0306 4 2023-01-01 0001840233 Xilio Therapeutics, Inc. XLO 0001653276 Huber Martin H. Jr. 828 WINTER STREET SUITE 300 WALTHAM MA 02451 false true false false PRESIDENT AND HEAD OF R&D Stock Option (right to buy) 2.69 2023-01-01 4 A 0 136500 0 A 2032-12-31 Common Stock 136500 136500 D The option award was granted on January 1, 2023 and shall vest on February 1, 2023 with respect to 1/48th of the shares of common stock underlying the stock option and continue to vest in equal monthly installments thereafter until January 1, 2027. /s/ Chris Frankenfield, Attorney-in-Fact 2023-01-04